Skip to content
healthcare.dev

Aminocaproic Acid

NDC 16571-326, Aminocaproic Acid, tablet, from RISING PHARMA HOLDINGS, INC..

Product NDC
16571-326
Status
Listed
Labeler
RISING PHARMA HOLDINGS, INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213944
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-326 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMINOCAPROIC ACID500 mg/1

Pharmacologic classes

Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]

Package NDCNDC-11Package
16571-326-031657103260330 TABLET in 1 BOTTLE (16571-326-03)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ae768406-955e-4863-9549-6c43662e5295

Use it

Look up 16571-326 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-326 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-326. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.